Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Risk Assessment Hospitalization Outcomes Epidemiology Efficacy

NCT04678193 is registered in ClinicalTrials.gov with Aventyn, Inc. as lead sponsor.

NCT NCT04678193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04678193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Risk Assessment Hospitalization Outcomes Epidemiology Efficacy
Lead sponsor
Aventyn, Inc.
Phase
Observational
Overall status
Unknown status
Start date
December 24, 2020
Completion date
June 30, 2026
Enrollment
27,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid19